
Public drug program spending in Canada by therapy share 2021
This statistic shows the proportion of the total public drug program expenditures in Canada by broad therapeutic category in 2021. In that year, some 25 percent of total drug program spending was dedicated to antineoplastic and immunomodulating agents.